Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Portland, Oregon 97239


The purpose of this study is to determine whether early use of a bland emollient in newborns, prior to the clinical signs of skin disease, will delay the onset or prevent the development of atopic dermatitis.

Study summary:

All neonates will be treated with Cetaphil cream starting within 1 week of birth. All neonates enrolled will have an increased risk of developing atopic dermatitis because they have a family history of either asthma, hay fever, or atopic dermatitis. These neonates will then be followed for 2 years for the signs and symptoms of atopic dermatitis.


Inclusion Criteria: - at least one parent diagnosed with Atopic Dermatitis - one parent or sibling with hayfever or asthma Exclusion Criteria: - newborns with dermatitis at birth - newborns born greater than four weeks prematurely - newborns with medical problems necessitating prolonged hospitalization - newborns diagnosed with any immune deficiency syndrome



Primary Contact:

Principal Investigator
Eric Simpson, MD
Oregon Health and Science University

Maureen Keene
Phone: 503-228-7350

Backup Contact:


Location Contact:

Portland, Oregon 97239
United States

Maureen Keene
Phone: 503-228-7350

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.